Under these cautions, MT1-MMP inhibitors could potentially be promising agents that induce various advantages not just for cancer treatments but also for other diseases including rheumatoid arthritis, age-associated diabetes, and atherosclerosis. The gene discussed is MMP14; the disease is rheumatoid arthritis.